Amgen : The Story of Maridebart Cafraglutide (MariTide)

AMGN

Published on 05/11/2026 at 07:50 pm EDT

This is an abstract of the document. To keep reading, click here and get access to the original version.

Disclaimer

Amgen Inc. published this content on May 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 11, 2026 at 23:49 UTC.